1st Quarter - Report
PODESTA GROUP, INC. for BRISTOL-MYERS SQUIBB
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
LHHS appropriations Diabetes research issues Comparative effectiveness
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BRATHWAITE | Exec. Dir., Congressional Black Caucus |
| SHARON COHEN | — |
| THOMAS B SPARKMAN | Health Policy Intern, Senate HELP Committee |
Copyright/Patent/Trademark CPT
H.R. 1260 Patent Reform Act of 2009 S. 515 Patent Reform Act of 2009
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIELE BAIERLEIN | — |
| PAUL BRATHWAITE | Exec. Dir., Congressional Black Caucus |
| SHARON COHEN | — |
| COURTNEY HAGEN | — |
| THOMAS B SPARKMAN | Health Policy Intern, Senate HELP Committee |
Medicare/Medicaid MMM
Medicare Issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BRATHWAITE | Exec. Dir., Congressional Black Caucus |
| SHARON COHEN | — |
| THOMAS B SPARKMAN | Health Policy Intern, Senate HELP Committee |
Budget/Appropriations BUD
H.R. 1 American Recovery and Reinvestment Act of 2009 S. Con. Res. 13 H. Con. Res. 85
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHARON COHEN | — |
| THOMAS B SPARKMAN | Health Policy Intern, Senate HELP Committee |
Pharmacy PHA
H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathyway for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act Drug Importation/Drug Safety
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BRATHWAITE | Exec. Dir., Congressional Black Caucus |
| SHARON COHEN | — |
| THOMAS B SPARKMAN | Health Policy Intern, Senate HELP Committee |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.